Medical device case studies: writing customer stories that survive regulatory review

Which stories work for medical device companies?

The stories that get approved and get used are about how a device entered a care setting and what changed operationally, not about how patients fared. Four types come up again and again.

• Implementation and go-live. How a hospital or clinic brought the device in: the timeline, the stakeholders, the obstacles, what the vendor did well. Prospects buying the same device want to know what the rollout looks like.
• Training and adoption. How clinical staff were trained, how long it took to reach confident use, what the learning curve was. Adoption risk is one of the biggest objections in device purchasing.
• Clinical workflow change. How the device changed the sequence of work in an OR, a lab, a sterile processing department, or a ward. Measurable in time, steps, or staffing rather than in patient outcomes.
• Commercial rollout. How a health system standardised on a device across multiple sites, and what the procurement and governance process involved.

Each of these can carry real numbers (turnaround time, training hours, cases per month, sites live) without making a claim about safety or efficacy. That is what makes them approvable.

What claims can a medical device case study make?

A case study is promotional material. In the United States, promotional claims about a device need to be consistent with its cleared or approved intended use and supported by adequate evidence; claims that go beyond labeling, or that are misleading by omission, can render the device misbranded. Other markets have equivalent rules. Your regulatory team knows the specifics for your device and jurisdiction, and the case study has to live inside those limits.

In practice that means three categories of statement.

The trap is the third row. A clinician will often say something in a conversation that, written down in marketing material, becomes an unsupported claim. The customer's enthusiasm does not change the regulatory status of the statement. A good draft flags these before your reviewer has to.

How do you get a case study through regulatory and legal review?

Make the review a verification exercise rather than a reading exercise. Reviewers reject what they cannot check. Give them a document where everything is already checkable.

1. Name the reviewers before drafting. Regulatory affairs, legal, and, if clinical statements appear, medical affairs. Agree that marketing owns the story angle and that reviewers own the claims.
2. Supply the approved claims list with the brief. The draft should only make performance statements that are already on that list. Anything else gets written as a customer observation or left out.
3. Deliver a source ledger with the draft. A table listing every claim, its exact wording, the document or transcript it came from, and its approval status. This is the single biggest accelerator of review we know of.
4. Mark the draft. Sourced claims, pending customer approvals, and open questions should be visibly different in the document, so a reviewer can see at a glance what still needs attention.
5. Run one consolidated round. Collect all reviewer comments before changing anything. Serial review, where legal sees a draft that regulatory has already edited, is how six-week delays happen.

The approval workflow guide goes deeper on who signs off on what and in what order.

How should a medical device case study be structured?

The standard five-part structure works, with device-specific emphasis in two places.

1. The setting and the problem. Type and size of facility, the department, the operational problem, and what it cost in time, delays, or staffing. Name the facility only with written permission; an anonymised description is fine and often preferred.
2. Why they chose the device. What was evaluated, what the deciding factors were. For devices this is often about integration, training burden, and vendor support, not features.
3. Implementation. Timeline, who was involved, training, obstacles. More detail here than in other industries, because rollout risk is the prospect's main worry.
4. What changed. Operational measures with periods and sources. Qualitative observations attributed to the person who made them.
5. What a buyer should learn. A short, practical takeaway about adoption or rollout, not a claim about outcomes.

Keep the whole thing to 600 to 900 words. Longer drafts give reviewers more to object to without giving prospects more reason to buy.

How do you handle clinician quotes?

Three rules. First, quotes come from a transcript, an email, or written notes, never from a writer's reconstruction of what the clinician probably meant. Second, the clinician approves the exact wording in writing before publication, and that approval is recorded with the date. Third, a quote that contains a performance, safety, or efficacy claim is treated as a claim, not as a quote. If it cannot be supported, it is cut, however good it sounds.

Many institutions require their own communications office to approve any quote attributed to staff, and some prohibit staff endorsements entirely. Ask early. An anonymised role ("the sterile processing manager") is often the workable path when a named quote is not.

What mistakes get medical device case studies rejected?

• Turning an estimate into a statistic. "About a third fewer" becomes "33 percent fewer." The reviewer asks for the data. There is none.
• Implying an outcome from an anecdote. A nurse says patients seemed more comfortable; the draft says the device improves patient comfort.
• Comparative claims about competitors. Even when the customer volunteers them, they need substantiation you probably don't have.
• Naming a facility that never agreed to be named. Permission status should be known before the draft exists, not after.
• Using images without rights. Facility photos, logos, and staff images each need documented permission.
• Treating the customer's internal data as public. Dashboard exports and reports often need the customer's own approval to be cited, even anonymously.

Every one of these is caught by the same discipline: a source ledger built before drafting, and a permission check before anyone writes a word. That is how Case Study Works produces device stories: you upload the material and the approved claims, our system drafts within those limits and marks everything, and your reviewers verify. Our sample draft shows what the marked-up version looks like.

Frequently asked questions